Gebruikt door |
als |
Naam |
Versie |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9071 |
Inclusie |
MP Ingredient quantity (9)
|
2016‑06‑18 20:41:53 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9106 |
 |
MP CDA Ingredient (9)
|
2016‑06‑26 16:40:13 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9070 |
 |
MP CDA Medication Information (9.0.6)
|
2016‑06‑18 19:34:27 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9148 |
 |
MP CDA Medicatieafspraak (9.0.5)
|
2016‑07‑25 13:04:13 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9152 |
 |
MP CDA Toedieningsafspraak (9.0.5)
|
2016‑07‑26 16:33:18 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9163 |
 |
MP CDA Medication Information (Proposal/Statement) (9)
|
2016‑11‑13 13:51:19 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9190 |
 |
MP CDA Medicatiegebruik (9.0.5)
|
2017‑10‑25 12:01:41 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9264 |
 |
MP CDA Medication Contents (9)
|
2018‑12‑11 15:49:05 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9254 |
 |
MP CDA Medication Information (9)
|
2018‑12‑06 14:34:51 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9233 |
 |
MP CDA Medicatieafspraak inhoud (9)
|
2018‑12‑04 13:05:47 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9235 |
 |
MP CDA Medicatieafspraak (9)
|
2018‑12‑04 14:33:21 |
2.16.840.1.113883.2.4.3.11.60.42.10.10 |
 |
BgZ2017 Medicatie
|
2017‑10‑24 |
2.16.840.1.113883.2.4.3.11.60.42.10.3 |
 |
BgZ2017 StructuredBody SDTC
|
2017‑10‑24 18:08:26 |
2.16.840.1.113883.2.4.3.11.60.42.10.2 |
 |
BgZ2017 component SDTC
|
2017‑10‑24 18:07:08 |
2.16.840.1.113883.2.4.3.11.60.42.10.1 |
 |
CDA Basisgegevensset Zorg 2017 (BgZ)
|
2017‑10‑24 18:05:40 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9241 |
 |
MP CDA Medicatieafspraak andermans (9)
|
2018‑12‑04 15:06:24 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9256 |
 |
MP CDA Toedieningsafspraak inhoud (9)
|
2018‑12‑06 15:04:55 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9258 |
 |
MP CDA Toedieningsafspraak andermans (9)
|
2018‑12‑06 16:02:48 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9259 |
 |
MP CDA Toedieningsafspraak (9)
|
2018‑12‑06 16:05:23 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9263 |
 |
MP CDA Medication Information Proposal Statement (9)
|
2018‑12‑11 15:40:12 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9250 |
 |
MP CDA Medicatiegebruik inhoud (9)
|
2018‑12‑05 11:15:32 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9246 |
 |
MP CDA Medicatiegebruik (9)
|
2018‑12‑05 10:16:27 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9248 |
 |
MP CDA Medicatiegebruik andermans (9)
|
2018‑12‑05 10:33:59 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9164 |
Inclusie |
DoseQuantity and translation(s) (9)
|
2017‑01‑18 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9048 |
 |
DoseQuantity (9)
|
2016‑06‑14 14:58:40 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9149 |
 |
MP CDA Dosering (9)
|
2016‑07‑25 13:43:40 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9181 |
 |
MP CDA (voorstel) Medicatieafspraak onderdelen 2 (9.0.6)
|
2017‑05‑31 11:12:41 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9234 |
 |
MP CDA (voorstel) Medicatieafspraak onderdelen 2 (9)
|
2018‑12‑04 14:08:53 |
2.16.840.1.113883.2.4.3.11.60.20.77.10.9064 |
 |
maxDoseQuantity (9)
|
2016‑06‑01 |